Literature DB >> 8063789

Crystal structure of ribonuclease A.d(ApTpApApG) complex. Direct evidence for extended substrate recognition.

J C Fontecilla-Camps1, R de Llorens, M H le Du, C M Cuchillo.   

Abstract

The crystal structure of the complex between ribonuclease A and d(ApTpApApG) has been solved by x-ray crystallography using the molecular replacement method. The model includes, besides the enzyme, the d(ApTpApA) 5'-segment (A1T2A3A4) and 68 solvent molecules. The R-factor for the strongest 87% of the measured data that partially extends to 2.3-A resolution is 0.207. The A1 position is well defined; the 5'-O of the deoxyribose establishes a hydrogen bond with a solvent molecule that is, in turn, bonded to the epsilon-amino group of Lys66. The base (B0 site) is well ordered; it interacts with a symmetry-related enzyme molecule. In the crystal, the phosphate group at the p0 site has no direct charge compensation. However, Lys66 is not too far, and, in solution, it could bind to it. The T2 (R1B1p1) site is occupied as in other complex structures, and it is defined by very good electron density. The A3 site shows that the adenine moiety interacts with Asn71 and Gln69 and that the phosphate at p2 forms a salt bridge with Lys7. The most consistent model for the base of A4 (B3), both in terms of electron density and stereochemistry, shows that it forms a hydrogen bond with Gln69 and a g-g- array with the base at B2. The stacking of B2 and B3 may be a general feature of the binding of polyribonucleotides to ribonuclease A. The side chains of Gln69, Asn71, and Glu111 may thus constitute a malleable binding site capable of establishing various hydrogen bonds depending on the nature of the stacked bases. There is no evidence for the 3' G5 site in the electron density map.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063789     DOI: 10.2210/pdb1rcn/pdb

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.

Authors:  Natalia G Beloglazova; Martin M Fabani; Marina A Zenkova; Elena V Bichenkova; Nikolai N Polushin; Vladimir V Sil'nikov; Kenneth T Douglas; Valentin V Vlassov
Journal:  Nucleic Acids Res       Date:  2004-07-23       Impact factor: 16.971

2.  Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.

Authors:  Daniel E Holloway; Gayatri B Chavali; Michelle C Hares; Vasanta Subramanian; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-11-19

3.  Structural and biochemical insights into the dicing mechanism of mouse Dicer: a conserved lysine is critical for dsRNA cleavage.

Authors:  Zhihua Du; John K Lee; Richard Tjhen; Robert M Stroud; Thomas L James
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

4.  Contaminant inclusion into protein crystals analyzed by electrospray mass spectrometry and X-ray crystallography.

Authors:  J Hirschler; F Halgand; E Forest; J C Fontecilla-Camps
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

5.  Thermal unfolding of ribonuclease A in phosphate at neutral pH: deviations from the two-state model.

Authors:  S D Stelea; P Pancoska; A S Benight; T A Keiderling
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

6.  A phosphate-binding subsite in bovine pancreatic ribonuclease A can be converted into a very efficient catalytic site.

Authors:  Mohammed Moussaoui; Claudi M Cuchillo; M Victòria Nogués
Journal:  Protein Sci       Date:  2007-01       Impact factor: 6.725

7.  A new crystal form of bovine pancreatic RNase A in complex with 2'-deoxyguanosine-5'-monophosphate.

Authors:  Steven B Larson; John S Day; Robert Cudney; Alexander McPherson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-31

8.  Three-dimensional structure of the complexes of ribonuclease A with 2',5'-CpA and 3',5'-d(CpA) in aqueous solution, as obtained by NMR and restrained molecular dynamics.

Authors:  C Toiron; C González; M Bruix; M Rico
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

9.  Inhibitor design for ribonuclease A: the binding of two 5'-phosphate uridine analogues.

Authors:  Vicky G Tsirkone; Kyriaki Dossi; Christina Drakou; Spyros E Zographos; Maria Kontou; Demetres D Leonidas
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-06-27

10.  Influence of naturally-occurring 5'-pyrophosphate-linked substituents on the binding of adenylic inhibitors to ribonuclease a: an X-ray crystallographic study.

Authors:  Daniel E Holloway; Gayatri B Chavali; Demetres D Leonidas; Matthew D Baker; K Ravi Acharya
Journal:  Biopolymers       Date:  2009-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.